Cell Lysis/Cell Fractionation Market

Cell Lysis/Cell Fractionation Market by Product (Consumables (Enzymes, Detergent), Instruments (Sonicators)), Cell Type (Mammalian), Application (Protein Purification), End User (Biopharmaceutical & Biotechnology Companies) - Global Forecast to 2026

Report Code: BT 4209 Mar, 2021, by marketsandmarkets.com

[172 Pages Report] The global cell lysis market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 7.2% during the forecast period. Growth of the market is driven mainly by increasing government funding for research, high prevalence of diseases and growing focus on personalized medicine.

Cell Lysis/Cell Fractionation Market

To know about the assumptions considered for the study, download the pdf brochure

Covid -19 Impact On The Cell Lysis Market

Due to the rapid spread of the coronavirus, the demand for diagnostic kits and other critical care medical devices has witnessed exponential growth in the last two quarters. Currently, healthcare provider facilities across the globe are overwhelmed with patient submissions for COVID-19 screening & treatment. This has resulted in severe disruptions in clinical workflows within inpatient care facilities, leading to prioritizing critical patient care procedures by provider facilities. However, government and corporate investments have increased significantly to drive the manufacturing and supply of medical supplies required to cater to infected patients. This has pressured stakeholders to strengthen their existing manufacturing capabilities and supply chains. The life sciences industry and multinational organizations & smaller companies are working round-the-clock to meet this demand and make tests available.

Global Cell Lysis Market Dynamics

DRIVER: Increasing government funding for research

Researchers utilize disrupted cells to study an organelle’s morphology and function and develop new cell therapies and other cell-based treatments. Owing to the importance of cell-based research, various government bodies have increased support for the growth of such research studies. Many government organizations have extended their help in the form of investments, funds, and grants. For instance, in March 2020, the Government of Canada invested around USD 7.0 million through the Stem Cell Network’s competitive research funding program to support stem cell research in Canada. In 2019, the Minister of Science and Sport (Canada) announced funding of USD 22.7 million, in addition to funding of USD 33.4 million by provincial governments to support 36 research projects through Genome Canada. The projects include various sectors such as health, agriculture, natural resources, and the environment

OPPORTUNITY: Growing opportunity in emerging markets

Emerging countries such as China, Brazil, Mexico, and India present significant opportunities for players in the cell lysis market. The major reasons for this are the increasing prevalence of chronic diseases, improvements in infrastructure facilities for research, and favorable legislation for cell-based research in emerging countries. Owing to this, key industry players strengthen their presence in emerging countries like China by establishing new facilities and R&D and innovation centers in the region.

CHALLENGE: Survival of small players and new entrants

The survival of small players and new entrants in the cell lysis market is a significant challenge. Huge investments are required for the R&D and launch of innovative products in the market. Thus, to remain competitive in the market, companies have to invest heavily. Moreover, market players have to reduce operational costs to successfully survive in the market, which is very difficult for small players and new entrants.

The consumables segment is expected to grow at the highest CAGR during the forecast period

Based on the product, the cell lysis market is segmented into consumables and instruments. The consumables segment is projected to witness the highest growth during the forecast period. The repeated purchase and high consumption, the high prevalence of diseases, and increasing funding for cell-based research  are the major factors supporting the growth of this segment.

The mammalian cell segment accounted for the largest share of the cell lysis market in 2020

By cell type, the mammalian cell market is segmented into mammalian, microbial, and other cells. The inframammary fold segment accounted for the largest market share in 2020. The large share of this segment can be attributed to Increasing investments in research activities to develop new disease treatments and industrial applications.

Research laboratories and institutes for the largest share of the cell lysis market in 2020

Based on end-users, the cell lysis market is segmented into biopharmaceutical & biotechnology companies, research laboratories & institutes, and other end users. The research laboratories & institutes segment accounted for the largest share of the cell lysis market in 2020. The increasing rising government funding for cell-based research is one of the major driving factor for this market.

Cell Lysis/Cell Fractionation Market  by Region

North America accounted for the largest share of the cell lysis market in 2020

Based on the region, the cell lysis market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2020, North America accounted for the largest share of the cell lysis market. The large share of North America can be attributed to factors such as growing stem cell and cancer research activities and the expanding biotechnology & pharmaceutical industries

Key Market Players

Some of the major players operating in this market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), and  Becton, Dickinson and Company (US). In 2020, Thermo Fisher Sicnetific Inc. held the leading position in the  market. The The company has a strong geographic presence across the US, China, Germany, and the UK. Moreover, the company’s strong brand recognition and comprehensive product portfolio in the cell lysis market is its key strength. Merck held the second position in the cell lysis market in 2020.

Scope of the report

Report Metric

Details

Market Size Available for Years

2019–2026

Base Year Considered

2018

Forecast Period

2021–2026

Forecast Units

Value (USD Billion)

Segments Covered

Products, Cell Type, Application, End User and Region

Geographies Covered

North America (US, Canada), Europe (Germany, France, UK, Spain, Italy, and RoE), APAC (China, India, Japan and the RoAPAC), and Rest of the World

Companies Covered

Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Danaher Corporation (US), and Bio- Rad Laboratories (US), Cell Signaling Technology Inc. (US), Miltenyi Biotec (Germany), Roche Diagnostics (Switzerland), QIAGEN N.V. (Netherlands), Qsonica LLC (US), STEMCELL Technologies Inc. (Canada), and PromoCell GmbH (Germany), NZYTech Lda (Portugal), Labfreez Instruments Group Co., Limited (China), G-Biosciences (US), Covaris (US), Claremont BioSolutions LLC (US), Microfluidics International Corporation (US), Parr Instrument Company (US), BioVision Inc.(US), and Norgen Biotek (Canada)

This research report categorizes the cell lysis market into the following segments and subsegments:

  • Product
    • Consumables
      • Kits and Reagents
        • Enzymes
        • Detergent Solutions
        • Others
    • Instruments .
      • Sonicators
      • Homogenizers
      • Other Instruments
  • Cell Type
    • Mammalian Cells
    • Microbial Cells
    • Other Cells
  • Application
    • Protein Purificaton and Isolation
    • Nucleic Acid  Isolation and Purification
    • Other Application
  • End User
    • Research Laboratories and Institutes
    • Biopharmaceutical and Biotechnology Comapanies
    • Other End User
  • Region
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • RoE
    • Asia Pacific
      • China
      • India
      • Japan
    • RoAPAC
  • Rest of the World

Recent Developments:

  • In 2020, Thermo Fisher Scientific entered into collaboration with Northeastern University To advance analytical capabilities and accelerate innovation across the biopharmaceutical industry in personalized medicine, monoclonal antibodies, and gene & cell therapies
  • In 2020, Danaher Corporation acquired biopharma business from GE Company’s life science segment.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 25)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 MARKET STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 29)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
           FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
           FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
           FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (APPLICATION-BASED)
           FIGURE 6 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 38)
           FIGURE 8 CELL LYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
           FIGURE 9 CELL LYSIS MARKET, BY CELL TYPE, 2021 VS. 2026 (USD MILLION)
           FIGURE 10 CELL LYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
           FIGURE 11 CELL LYSIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
           FIGURE 12 CELL LYSIS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 42)
    4.1 CELL LYSIS MARKET OVERVIEW
           FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE DRIVES THE GROWTH OF THE MARKET
    4.2 CELL LYSIS MARKET, BY PRODUCT
           FIGURE 14 CONSUMABLES DOMINATE THE PRODUCTS MARKET
    4.3 NORTH AMERICA: CELL LYSIS MARKET, BY PRODUCT, 2020
           FIGURE 15 US DOMINATED THE CELL LYSIS MARKET IN 2020
    4.4 GEOGRAPHICAL SNAPSHOT OF THE CELL LYSIS MARKET
           FIGURE 16 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 44)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 17 CELL LYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing government funding for research
           FIGURE 18 NIH FUNDING, BY RESEARCH AREA, 2016–2021 (USD MILLION)
                    5.2.1.2 High prevalence of diseases
           TABLE 1 RISING INCIDENCES OF DISEASES
                    5.2.1.3 Growing focus on personalized medicine
           FIGURE 19 RISING NUMBER OF PERSONALIZED MEDICINES, 2008–2020
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of cell-based research and instruments
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging countries
           5.2.4 CHALLENGES
                    5.2.4.1 Survival of small players and new entrants
    5.3 COVID-19 IMPACT ANALYSIS
    5.4 VALUE CHAIN ANALYSIS
           FIGURE 20 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
    5.5 SUPPLY CHAIN ANALYSIS
           FIGURE 21 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
    5.6 ECOSYSTEM ANALYSIS OF THE CELL LYSIS MARKET
           FIGURE 22 ECOSYSTEM ANALYSIS OF THE CELL LYSIS MARKET
    5.7 PRICING ANALYSIS
           TABLE 2 PRICES OF CELL LYSIS PRODUCTS
    5.8 PORTER’S FIVE FORCES ANALYSIS
           5.8.1 THREAT FROM NEW ENTRANTS
           5.8.2 INTENSITY OF COMPETITIVE RIVALRY
           5.8.3 BARGAINING POWER OF BUYERS
           5.8.4 BARGAINING POWER OF SUPPLIERS
           5.8.5 THREAT FROM SUBSTITUTES
    5.9 TECHNOLOGY ANALYSIS
    5.10 PATENT ANALYSIS
    5.11 REGULATORY OUTLOOK
    5.12 TRADE ANALYSIS
           TABLE 3 EXPORT DATA FOR HOMOGENIZERS, BY COUNTRY, 2016—2020 (USD MILLION)
           TABLE 4 IMPORT DATA FOR HOMOGENIZERS, BY COUNTRY, 2016—2020 (USD MILLION)

6 CELL LYSIS MARKET, BY PRODUCT (Page No. - 55)
    6.1 INTRODUCTION
           TABLE 5 CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
    6.2 CONSUMABLES
           TABLE 6 CELL LYSIS CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
           TABLE 7 CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           6.2.1 REAGENTS & KITS
           TABLE 8 CELL LYSIS REAGENTS & KITS MARKET, BY REGION, 2019–2026 (USD MILLION)
           TABLE 9 CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    6.2.1.1 Enzymes
                               6.2.1.1.1 Enzymes dominated the reagents & kits market in 2020
           TABLE 10 CELL LYSIS ENZYMES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    6.2.1.2 Detergent solutions
                               6.2.1.2.1 Growing research in cell biology is a key factor driving market growth
           TABLE 11 CELL LYSIS DETERGENT SOLUTIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    6.2.1.3 Other reagents & kits
           TABLE 12 OTHER CELL LYSIS REAGENTS & KITS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.2.2 BEADS
                    6.2.2.1 Increasing investments in cell-based research form a major growth factor in this market
           TABLE 13 CELL LYSIS BEADS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.2.3 DISPOSABLES
                    6.2.3.1 North America to show the highest demand for cell lysis disposables
           TABLE 14 CELL LYSIS DISPOSABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.3 INSTRUMENTS
           TABLE 15 CELL LYSIS INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
           TABLE 16 CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           6.3.1 SONICATORS
                    6.3.1.1 Sonicators accounted for the largest share of the instruments market in 2020
           TABLE 17 CELL LYSIS SONICATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.3.2 HOMOGENIZERS
                    6.3.2.1 Investments in research and technological advancements drive market growth
           TABLE 18 CELL LYSIS HOMOGENIZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.3.3 OTHER INSTRUMENTS
           TABLE 19 OTHER CELL LYSIS INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)

7 CELL LYSIS MARKET, BY CELL TYPE (Page No. - 64)
    7.1 INTRODUCTION
           TABLE 20 CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
    7.2 MAMMALIAN CELLS
           7.2.1 MAMMALIAN CELLS TO DOMINATE THE CELL LYSIS MARKET
           TABLE 21 CELL LYSIS MARKET FOR MAMMALIAN CELLS, BY REGION, 2019–2026 (USD MILLION)
    7.3 MICROBIAL CELLS
           7.3.1 INCREASING INVESTMENT ON BIOPHARMACEUTICAL R&D TO DRIVE MARKET GROWTH
           TABLE 22 CELL LYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2019–2026 (USD MILLION)
    7.4 OTHER CELLS
           TABLE 23 CELL LYSIS MARKET FOR OTHER CELLS, BY REGION, 2019–2026 (USD MILLION)

8 CELL LYSIS MARKET, BY APPLICATION (Page No. - 68)
    8.1 INTRODUCTION
           TABLE 24 CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    8.2 PROTEIN PURIFICATION & ISOLATION
           8.2.1 PROTEIN PURIFICATION AND ISOLATION TO DOMINATE THE CELL LYSIS MARKET DURING THE FORECAST PERIOD
           TABLE 25 CELL LYSIS MARKET FOR PROTEIN PURIFICATION & ISOLATION, BY REGION, 2019–2026 (USD MILLION)
    8.3 NUCLEIC ACID PURIFICATION & ISOLATION
           8.3.1 INCREASING INVESTMENT IN BIOPHARMACEUTICAL R&D TO DRIVE MARKET GROWTH
           TABLE 26 CELL LYSIS MARKET FOR NUCLEIC ACID ISOLATION & PURIFICATION, BY REGION, 2019–2026 (USD MILLION)
    8.4 OTHER APPLICATIONS
           TABLE 27 CELL LYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)

9 CELL LYSIS MARKET, BY END USER (Page No. - 72)
    9.1 INTRODUCTION
           TABLE 28 CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.2 RESEARCH LABORATORIES & INSTITUTES
           9.2.1 RISING RESEARCH FUNDING SUPPORTS MARKET GROWTH
           TABLE 29 CELL LYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
    9.3 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           9.3.1 RISING INVESTMENTS IN CELL-BASED RESEARCH AND THERAPY DEVELOPMENT WILL DRIVE MARKET GROWTH
           TABLE 30 CELL LYSIS MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 
    9.4 OTHER END USERS 75
           TABLE 31 CELL LYSIS MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION) 

10 CELL LYSIS MARKET, BY REGION (Page No. - 76)
     10.1 INTRODUCTION
           TABLE 32 CELL LYSIS MARKET, BY REGION, 2019–2026 (USD MILLION)
     10.2 NORTH AMERICA
           FIGURE 23 NORTH AMERICA: MARKET SNAPSHOT
           TABLE 33 NORTH AMERICA: CELL LYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 34 NORTH AMERICA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 35 NORTH AMERICA: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 36 NORTH AMERICA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 37 NORTH AMERICA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 38 NORTH AMERICA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 39 NORTH AMERICA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 40 NORTH AMERICA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.1 US
                        10.2.1.1 The US dominates the market for cell lysis
           TABLE 41 US: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 42 US: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 43 US: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 44 US: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,2019–2026 (USD MILLION)
           TABLE 45 US: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 46 US: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 47 US: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 The strong and growing biopharmaceutical and biotechnology sector indicates a favorable outlook for cell lysis
           TABLE 48 CANADA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 49 CANADA: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 50 CANADA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 51 CANADA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,2019–2026 (USD MILLION)
           TABLE 52 CANADA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 53 CANADA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 54 CANADA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.3 EUROPE
           TABLE 55 EUROPE: CELL LYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 56 EUROPE: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 57 EUROPE: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 58 EUROPE: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 59 EUROPE: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 60 EUROPE: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 61 EUROPE: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 62 EUROPE: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Germany dominated the European cell lysis market in 2020
           TABLE 63 GERMANY: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 64 GERMANY: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 65 GERMANY: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 66 GERMANY: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 67 GERMANY: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 68 GERMANY: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 69 GERMANY: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Government initiatives to support market growth
           TABLE 70 UK: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 71 UK: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 72 UK: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 73 UK: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 74 UK: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 75 UK: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 76 UK: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Increasing R&D investment by players to support market growth
           TABLE 77 FRANCE: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 78 FRANCE: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 79 FRANCE: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,2019–2026 (USD MILLION)
           TABLE 80 FRANCE: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 81 FRANCE: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 82 FRANCE: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 83 FRANCE: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Large life science research base and rising awareness support the market in Italy
           TABLE 84 ITALY: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 85 ITALY: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 86 ITALY: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 87 ITALY: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 88 ITALY: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 89 ITALY: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 90 ITALY: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Increasing private and public funding to boost the market growth
           TABLE 91 SPAIN: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 92 SPAIN: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 93 SPAIN: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 94 SPAIN: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 95 SPAIN: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 96 SPAIN: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 97 SPAIN: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.6 REST OF EUROPE
           TABLE 98 ROE: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 99 ROE: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 100 ROE: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 101 ROE: CELL LYSIS INSTRUMENTS MARKET, BY TYPE,2019–2026 (USD MILLION)
           TABLE 102 ROE: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 103 ROE: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 104 ROE: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.4 ASIA PACIFIC
           FIGURE 24 ASIA PACIFIC: CELL LYSIS MARKET SNAPSHOT
           TABLE 105 ASIA PACIFIC: CELL LYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 106 ASIA PACIFIC: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 107 ASIA PACIFIC: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 108 ASIA PACIFIC: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 109 ASIA PACIFIC: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 110 ASIA PACIFIC: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 111 ASIA PACIFIC: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 112 ASIA PACIFIC: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 China to grow at the highest CAGR in the cell lysis market
           TABLE 113 CHINA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 114 CHINA: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 115 CHINA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 116 CHINA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 117 CHINA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 118 CHINA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 119 CHINA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Rising geriatric population and support for research drive market growth in Japan
           TABLE 120 JAPAN: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 121 JAPAN: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 122 JAPAN: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 123 JAPAN: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 124 JAPAN: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 125 JAPAN: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 126 JAPAN: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Increasing government initiatives on precision medicine will boost the market growth
           TABLE 127 INDIA: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 128 INDIA: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 129 INDIA: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE,2019–2026 (USD MILLION)
           TABLE 130 INDIA: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 131 INDIA: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 132 INDIA: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 133 INDIA: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.4 ROAPAC
           TABLE 134 ROAPAC: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 135 ROAPAC: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 136 ROAPAC: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 137 ROAPAC: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 138 ROAPAC: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 139 ROAPAC: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 140 ROAPAC: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.5 ROW
           TABLE 141 ROW: CELL LYSIS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 142 ROW: CELL LYSIS CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 143 ROW: CELL LYSIS REAGENTS & KITS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 144 ROW: CELL LYSIS INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 145 ROW: CELL LYSIS MARKET, BY CELL TYPE, 2019–2026 (USD MILLION)
           TABLE 146 ROW: CELL LYSIS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
           TABLE 147 ROW: CELL LYSIS MARKET, BY END USER, 2019–2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 122)
     11.1 OVERVIEW
           FIGURE 25 KEY DEVELOPMENTS IN THE CELL LYSIS MARKET, JANUARY 2018– FEBRUARY 2021
           FIGURE 26 MARKET EVOLUTION MATRIX: JANUARY 2018 TO JANUARY 2021
     11.2 MARKET SHARE ANALYSIS
           FIGURE 27 CELL LYSIS MARKET SHARE ANALYSIS, 2019
     11.3 COMPANY EVALUATION MATRIX
             11.3.1 STARS
             11.3.2 EMERGING LEADERS
             11.3.3 PERVASIVE PLAYERS
             11.3.4 PARTICIPANTS
           FIGURE 28 VENDOR DIVE: CELL LYSIS MARKET
     11.4 COMPETITIVE LEADERSHIP MAPPING (SMES/ START-UPS)
             11.4.1 PROGRESSIVE COMPANIES
             11.4.2 STARTING BLOCKS
             11.4.3 RESPONSIVE COMPANIES
             11.4.4 DYNAMIC COMPANIES
           FIGURE 29 VENDOR DIVE MATRIX FOR SMES & START-UPS: CELL LYSIS MARKET
     11.5 COMPETITIVE SCENARIO
             11.5.1 EXPANSIONS
           TABLE 148 KEY EXPANSIONS, JANUARY 2018–FEBRUARY 2021
             11.5.2 DEALS
           TABLE 149 KEY DEALS, JANUARY 2018–FEBRUARY 2021
             11.5.3 OTHER DEVELOPMENTS
           TABLE 150 OTHER KEY DEVELOPMENTS, JANUARY 2018–FEBRUARY 2021
     11.6 COMPANY PRODUCT FOOTPRINT
           FIGURE 30 PRODUCT PORTFOLIO ANALYSIS: CELL LYSIS MARKET
     11.7 COMPANY GEOGRAPHIC FOOTPRINT
           FIGURE 31 GEOGRAPHIC ASSESSMENT: CELL LYSIS MARKET

12 COMPANY PROFILES (Page No. - 130)
(Business Overview, Products Offered, Recent Developments, and MnM View)* 
     12.1 KEY PLAYERS
             12.1.1 THERMO FISHER SCIENTIFIC
           FIGURE 32 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
             12.1.2 MERCK
           FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2019)
             12.1.3 BIO-RAD LABORATORIES
           FIGURE 34 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
             12.1.4 BECKMAN COULTER
           FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
             12.1.5 BECTON, DICKINSON AND COMPANY
           FIGURE 36 BD: COMPANY SNAPSHOT (2020)
             12.1.6 CELL SIGNALING TECHNOLOGY
             12.1.7 MILTENYI BIOTEC
             12.1.8 ROCHE DIAGNOSTICS
           FIGURE 37 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)
             12.1.9 QIAGEN
           FIGURE 38 QIAGEN: COMPANY SNAPSHOT (2019)
             12.1.10 QSONICA
             12.1.11 STEMCELL TECHNOLOGIES
             12.1.12 PROMOCELL
             12.1.13 AGILENT TECHNOLOGIES
           FIGURE 39 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
             12.1.14 PROMEGA CORPORATION
     12.2 OTHER PLAYERS
             12.2.1 NZYTECH
             12.2.2 TAKARA BIO
           FIGURE 40 TAKARA BIO: COMPANY SNAPSHOT (2020)
             12.2.3 LABFREEZ INSTRUMENTS GROUP
             12.2.4 G-BIOSCIENCES (GENO TECHNOLOGY)
             12.2.5 COVARIS
             12.2.6 CLAREMONT BIOSOLUTIONS
             12.2.7 MICROFLUIDICS INTERNATIONAL CORPORATION
             12.2.8 PARR INSTRUMENT COMPANY
             12.2.9 BIOVISION
             12.2.10 NORGEN BIOTEK CORP.
*Details on Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies. 

13 APPENDIX (Page No. - 165)
     13.1 INSIGHTS OF INDUSTRY EXPERTS
     13.2 DISCUSSION GUIDE
     13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.4 AVAILABLE CUSTOMIZATIONS
     13.5 RELATED REPORTS
     13.6 AUTHOR DETAILS

The study involved four major activities in estimating the current size of the cell lysis market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (research laboratories & institutes, biopharmaceutical & biotechnology companies) and supply sides (cell lysis manufacturers and distributors).

The following is a breakdown of the primary respondents:

Cell Lysis/Cell Fractionation Market   Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell lysis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size-using the market size estimation processesthe market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cell lysis industry.

Report Objectives

  • To define, describe, and forecast the cell lysis market by product, cell type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall cell lysis market
  • To analyze the opportunities in the market for stakeholders and to provide details of
    the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely,
    North America, Europe, Asia Pacific, and the Rest of the World (RoW2)
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies3
  •  To track and analyze competitive developments such as collaboration, acquisitions and expansions in the cell lysis market
  • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis:
    • Product matrix, which gives a detailed comparison of the product portfolios of each company
  • Geographic Analysis: 
    • Further breakdown of the Rest of the World cell lysis market into Latin America, the Middle East, and Africa cell lysis market into specific countries and further breakdown of the European cell lysis market into specific countries
    • COVID-19

      Get in-depth analysis of the COVID-19 impact on the Cell Lysis/Cell Fractionation Market

      Benchmarking the rapid strategy shifts of the Top 100 companies in the Cell Lysis/Cell Fractionation Market

      Request For Special Pricing
      Report Code
      BT 4209
      Published ON
      Mar, 2021
      Choose License Type
      BUY NOW
      • SHARE
      X
      Request Customization
      Speak to Analyst
      Speak to Analyst
      OR FACE-TO-FACE MEETING
      PERSONALIZE THIS RESEARCH
      • Triangulate with your Own Data
      • Get Data as per your Format and Definition
      • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
      • Any level of Personalization
      REQUEST A FREE CUSTOMIZATION
      LET US HELP YOU!
      • What are the Known and Unknown Adjacencies Impacting the Cell Lysis/Cell Fractionation Market
      • What will your New Revenue Sources be?
      • Who will be your Top Customer; what will make them switch?
      • Defend your Market Share or Win Competitors
      • Get a Scorecard for Target Partners
      CUSTOMIZED WORKSHOP REQUEST
      ADJACENT MARKETS
      REQUEST BUNDLE REPORTS
      +1-888-600-6441
      • Call Us
      • +1-888-600-6441 (Corporate office hours)
      • +1-888-600-6441 (US/Can toll free)
      • +44-800-368-9399 (UK office hours)
      CONNECT WITH US
      ABOUT TRUST ONLINE
      ©2021 MarketsandMarkets Research Private Ltd. All rights reserved